The Indian Pharmaceutical Industry

The Indian pharmaceutical industry is growing at a rate of 14% per year [India Brand Equality Foundation, 2009]. It is in a very high rank in the third world in terms of technology, quality, and medication type. Due to the rapid expansion and complexity of the chemical and pharmaceutical industries, the volume and complexity of toxic waste water is increasing. Effective elimination of substances contained in pharmaceutical wastewater due to various biological products produced by chemical substances, pharmaceutical chemicals, plant products of plant factories such as analgesics, antibiotics, and antidepressants It is a difficult task. , Anti-diabetic drugs, oral contraceptives etc.

Today, the Indian pharmaceutical industry is the leader in Indian scientific industry and has a wide range of functions in complex pharmaceutical manufacturing and technology. The Indian pharmaceutical industry is a highly organized industry with an estimate of $ 4.5 billion and an annual growth rate of about 8-9%. It is ranked highest in the third world in terms of technology, quality and range of manufactured medicines. From simple headache medicines to complex antibiotics and complex cardiac compounds almost all kinds of medicines are now being produced locally.

India is changing and the Indian pharmaceutical industry is changing. Waves of manufactured and exported products developed by growing Indian pharmaceutical companies like Dr. Reddy and Dr. Ranbaxy are beginning to penetrate the world's pharmaceutical markets. India is expected to be doing more and more innovation in the current "Made in India" campaign. However, as shown below, Indian pharmaceutical companies are not always innovation oriented. Indeed, in the majority of the second half of the 20th century, Indian pharmaceutical companies were driven by government policies to focus on import substitutes based on counterfeit goods. For this purpose, they are encouraged to develop process technology capabilities to produce common variants of branded drugs developed by foreign multinationals.

Between the 1980s and the 1990s, the Indian pharmaceutical industry became one of the most exported industries in India's pharmaceutical industry, and over 30% of its products were exported to foreign markets. In 1991, domestic enterprises accounted for approximately 70 to 80% of market share of API and formulation. The trade deficit in the 1970s was replaced by the trade surplus of the 1980s. (Figure 2.1). In the fourth phase of industrial development in the 1990s, the policy system of the pharmaceutical industry changed drastically. Allowing drug cancellation with automated route, 100% foreign investment, and price control has been greatly reduced.